Enclear Receives Key Funding to Advance Therapies that Clear Toxic Proteins from Brain, Spinal Cord
Biotech company EnClear Therapies has announced $10 million in financing to help advance its proprietary platform for stopping the…
Articles by Mary Chapman
Patients, Supporters Worldwide Recognizing Rare Disease Day 2020
An abundance of events are afoot around the world to mark Rare Disease Day 2020 on Feb. 29. The…
ALS Activist Ed Rapp to Be Honored by Les Turner ALS Foundation
At the time of his stunning 2015 amyotrophic lateral sclerosis (ALS) diagnosis, Ed Rapp was a veteran Caterpillar…
Nonprofits RARE Courage, All Wheels Up Partner on Survey Seeking to Improve Air Travel for Wheelchair Users
Kevin Schaefer hadn’t been in an airport since he was 4 years old, so he had been looking forward to…
$1M Donation Creates Quebec’s First ALS Research Chair
A $1 million gift from the Manouk Djoukhadjian Family Foundation II will create Quebec’s first philanthropic research chair on…
ALS Association Invests $3M in Platform Trial to Accelerate Development of Treatments
To help accelerate development of effective treatments for amyotrophic lateral sclerosis (ALS), the ALS Association is investing…
END ALS Association Founder Lights Up Room With Holiday Spirit to Raise Disease Awareness
The founder of the END ALS Association, Masahiro “Hiro” Fujita, can no longer move and can barely communicate because…
BrainStorm Cell Therapeutics Wins 2020 ‘Buzz of BIO’ Award for Investigational Cellular Treatment
For its promising investigational therapeutic approach to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS),…
Answer ALS Project to Better Understand and Treat Disease Moves into New Phase
Touted as the largest amyotrophic lateral sclerosis (ALS) investigative effort to date, the Answer ALS research program has finished…
New ALS Investment Fund Partnership Seeks to Raise $100M to Accelerate Research
A new ALS Association partnership with the ALS Investment Fund II seeks to raise $100 million in new…